Kara Hayes, OD
Optometrist · Lake Worth, FLNPI 1083106934
Payments from drug & device makers
What this record shows
21 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 53.4% of the total. Reporting peaked in 2023 at $7,100 and has fallen 93.4% since, to $468 in 2025. Among optometrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $104.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$7K
- Coopervision Inc.$2K
- Johnson & Johnson Vision Care, Inc.$1K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$394
- Kala Pharmaceuticals, Inc.$345
- Alcon$340
- plus $2K from 15 others
What the payments were for
- Speaking & faculty fees$7,15053%
- Food & beverage$6,29647%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 18 | $7,183 |
| Coopervision Inc. | 28 | $2,062 |
| Johnson & Johnson Vision Care, Inc. | 30 | $1,156 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $394 |
| Kala Pharmaceuticals, Inc. | 3 | $345 |
| Alcon | 5 | $340 |
| Sight Sciences, Inc. | 4 | $290 |
| AbbVie(2 entities) | 3 | $281 |
| Novartis | 8 | $237 |
| Amgen(2 entities) | 3 | $234 |
| Sun Pharmaceutical Industries Inc. | 8 | $183 |
| Visionix USA, Inc | 2 | $155 |
| Dompe US, Inc. | 2 | $130 |
| Topcon Healthcare, Inc. | 2 | $104 |
| Optovue, Inc. | 1 | $86 |
| Optos, Inc. | 1 | $70 |
| Glaukos Corporation | 2 | $48 |
| LKC Technologies, Inc. | 1 | $47 |
| Eyevance Pharmaceuticals LLC | 2 | $42 |
| Rxsight Inc | 1 | $40 |
| Shire North American Group Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$3,572
- BIOTRUE$3,000
- VYZULTA$3,000
- ZYLET$3,000
- LOTEMAX SM$3,000
- PROLENSA$3,000
- MiSight Contact Lens$1,266
- Acuvue$593
- BIOTRUE ONE DAY$337
- ULTRA$331
- INVELTYS$230
- TEPEZZA$216
- TEARCARE SYSTEM$135
- XIIDRA$122
- BTOD$120
- Clariti Contact Lens$118
- TearCare$116
- VUITY$115
- EYSUVIS$115
- Oxervate$108
How this compares
$13,446 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in Lake Worth
- Hetel BhaktaLake Worth$28K
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$553K
- Nora CothranLargo$505K
- Michael SluskyNorth Port$384K
- Katie SpearDefuniak Springs$361K
- Karen HoffmanOrange Park$282K
- Ashley RothMiami Beach$261K
- Jessica SteenDavie$256K
- Mark DunbarMiami$236K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.